Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Osivax

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
​Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies based on its proprietary technology, oligoDOM®, which is designed to induce powerful CD8 T-cell responses. Osivax' mission is to revolutionize influenza prevention with a universal flu vaccine covering both current and future influenza infections by leveraging its unique oligoDOM® technology platform. Osivax was created ...
​Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies based on its proprietary technology, oligoDOM®, which is designed to induce powerful CD8 T-cell responses. Osivax' mission is to revolutionize influenza prevention with a universal flu vaccine covering both current and future influenza infections by leveraging its unique oligoDOM® technology platform. Osivax was created as a spin-off of Imaxio, a commercial-stage vaccine company, to accelerate the development of the oligoDOM® technology platform.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Osivax
France Flag
Country
Country
France
Address
Address
OSIVAX​​ ​99, rue de Gerland 69007 LYON
Telephone
Telephone
+33 4 37 65 55 03
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY